AIDS & Clinical: Symptoms of AIDS Related Opportunistic Infections and Their Effects On Human Body
AIDS & Clinical: Symptoms of AIDS Related Opportunistic Infections and Their Effects On Human Body
AIDS & Clinical: Symptoms of AIDS Related Opportunistic Infections and Their Effects On Human Body
Research
Review Article
Open Access
Symptoms of AIDS Related Opportunistic Infections and Their Effects on Human Body
Jeevani T
1
Abstract
HIV viruses have long term effects for the immune systems and further develop a number of varied illnesses such as fever, diarrhea, tuberculosis, pneumonia and skin infections. This condition is termed as AIDS Acquired Immune Deficiency Syndrome. Once the immune system is sufficiently weakened, such infections will develop and produce any of a wide range of symptoms. Some can be very severe some may lead to various cancers. There is no exact prediction for these symptoms. HIV testing is the only source to diagnose. The most difficult aspect of HIV/ AIDS is that though there are medicines, which can help with these illnesses but there is no vaccine and no cure for the HIV, so almost all the infected people become more and more ill and eventually die. It is important for every individual to know and understand about this infection.
Keywords: HIV; AIDS; Opportunistic infections; Tuberculosis; Pneumonia, Diarrhea; Helper T-cells; Neurological disorders; CD4+ T cells; Toxoplasmosis; Encephalopathy; Cryptosporidium; Mycobacterium; Candidiasis; Kaposis sarcoma; Shingles Abbreviations: HIV: System, Human lmmuno-deficiency Virus, AIDS: Acquired Immune Deficiency Syndrome, CNS: Central nervous system; PML: Progressive Multifocal Leukoencephalopathy, CMV: Cytomegalovirus, MAC: Mycobacterium Avium Complex, HSV: Herpes Simplex Virus, STD: Sexually Transmitted Disease, NHL: NonHodgkins Lymphoma, HHV: Human Herpes Virus, TB: Tuberculosis Introduction
We live in an environment of microorganisms and at every moment an enormous number of them are entering body [1]. It is the immune system that normally fights off these microorganisms and keeps body healthy. But over the last fifteen years a new disease spread by a family of viruses called HIV [2] which has spread globally. HIV stands for Human lmmunodeficiency Virus [3]. It has been given this name because of its long-term effect to attack the immune system of the body, making it weak and deficient. The virus has weakened the immune system so much that they develop a number of different illnesses such as tuberculosis [4], pneumonia, persistent diarrhea, and fever and skin infections. This condition is called AIDS Acquired Immune Deficiency Syndrome. It is not possible to reliably diagnose HIV infection [5] or AIDS based on symptoms alone. HIV symptoms are very similar to the symptoms of other illnesses. So the only way to know for sure whether a person is infected with HIV is for them to have a test. HIV testing is the only way to know for sure if the person is infected or not. However there is an assortment of HIV symptoms that can be associated with a new HIV infection. Earlier HIV diagnosis, substance abuse treatment [6], avoidance of breastfeeding, and use of prenatal antiretroviral medications [7] are critical in eliminating perinatal HIV infections [8]. When HIV enters into persons blood it attaches itself to a special type of white blood cells called helper T-Lymphocytes. These Helper Tcells [9,10] are crucial in defending the body against many infections. During all this the person will have no symptoms. They look well and feel well. They may not know that they now have the virus, but could pass it on to someone else through having sex [11,12], or by sharing needles or syringes. Being HIV Positive [13] is not the same as having AIDS.
J AIDS Clinic Res ISSN:2155-6113 JAR an open access journal
The HIV actually goes inside the white blood cells and lies their quietly. After 5 to 10 years the HIV virus tricks the cell to start making the viral proteins, this result in the formation of a huge number of viral particles inside the white cells and eventually the cells burst releasing thousands of new viruses in the blood. The released viruses infect new white cells. This cycle goes on and on, and eventually the immune system of the body gets affected. The use of combination of potent antiviral drugs leads to a reconstitution of the immune system [14]. Symptoms of AIDS are caused by the deterioration of the immune system and the decline of CD4+ T cells [15,16] which are the immune systems key infection fighters. As soon as HIV enters the body, it begins to destroy the cells. Eventually the infected person may lose weight and become ill with diseases like persistent severe diarrhea, fever, or pneumonia, or skin cancer [17]. He or she has now developed AIDS. There is no cure for HIV or for AIDS and so, it is almost certain that people diagnosed with AIDS will die. Some common symptoms include Diarrhea that lasts for more than a week, fever [18], Dry cough, Memory loss [19], depression and neurological disorders [20,21], Pneumonia, Profound unexplained fatigue, Rapid weight loss [22], Recurring fever or profuse night sweats, Red, brown, pink or purplish blotches on or under the skin or inside the mouth, nose or eyelids, Swollen lymph glands [23] in the armpits, groin or neck, White spots or unusual blemishes on the tongue, in the mouth, or in the throat.
Opportunistic Infections
If a person infected with HIV does not take effective antiretroviral treatment [24,25] over time HIV will weaken their immune system, which will make them much more vulnerable to opportunistic infections. This causes significant morbidity in both developed countries, where presentation with advanced HIV infection is common, and also in developing countries [16].
Corresponding author: Jeevani T, Department Of Biotechnology, Acharya Nagarjuna University, Guntur, India, E-mail: jeevanithot@yahoo.co.in Received October 25, 2011; Accepted December 13, 2011; Published December 20, 2011 Citation: Jeevani T (2011) Opportunistic Infections of Aids and Their Effects on Humans. J AIDS Clinic Res 2:132. doi:10.4172/2155-6113.1000132 Copyright: 2011 Jeevani T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation: Jeevani T (2011) Opportunistic Infections of Aids and Their Effects on Humans. J AIDS Clinic Res 2:132. doi:10.4172/2155-6113.1000132
Page 2 of 5 Opportunistic infections are caused by germs that are around us all the time but which can normally be fought off by a healthy immune system. Once the immune system [27] is sufficiently weakened, such infections will develop and produce any of a wide range of symptoms. Some of these symptoms can be very severe. Certain cancers also become more common when the immune system is weakened. Symptoms of opportunistic infections common with AIDS include Coma, Coughing and shortness of breath, Difficult or painful swallowing, Extreme fatigue, Fever, Mental symptoms such as confusion and forgetfulness, Nausea, abdominal cramps and vomiting, Seizures and lack of coordination, Severe, persistent diarrhea [28], Severe headaches, Vision loss and Weight loss. Many opportunistic infections associated with AIDS causes serious illness and some may be prevented. Although this virus can affect the entire body, it commonly affects the eyes retina, causing blurry vision and in severe cases, blindness. Other common symptoms include chronic diarrhea and nerve problems. It is most likely to occur when a persons CD4+ T cell count falls below 100 cells per cubic millimeter of blood.
Citation: Jeevani T (2011) Opportunistic Infections of Aids and Their Effects on Humans. J AIDS Clinic Res 2:132. doi:10.4172/2155-6113.1000132
Page 3 of 5 cause liver disease [55] or hepatitis. It is important that patients infected with hepatitis receive treatment and follow-up care. infection. It can affect the entire body, but most commonly occurs in the mouth (thrush) or vagina. An overgrowth of yeast causes white patches on gums, tongue or lining of the mouth, pain, difficulty in swallowing and loss of appetite. Candida in the esophagus, trachea, bronchi or lungs is AIDS defining.
Conclusion
AIDS may lead to several infections and diseases which are harmful as well as opportunistic. All the illnesses and conditions can also be found in people with other problems of the immune system, unrelated to HIV or AIDS. Therefore being diagnosed with any of these illnesses or conditions, by themselves, does not specifically indicate HIV infection or AIDS. So in order to get well knowledge about this controversy HIV testing is important. Opportunistic diseases are actually an entire group of diseases. Because these illnesses most often appear when the immune system is damaged, they are not usually associated with recent HIV infection but usually occur years after infection. Immunodeficiency was positively associated with all cancers examined except prostate cancer among HIV-infected compared with HIV-uninfected individuals, after adjustment for several cancer risk factors. Antiretroviral therapy initiation to maintain high CD4 levels might reduce the burden of cancer.
References
1. Thavasi R (2011) Microbial Biosurfactants: From an Environmental Application Point of View. J Bioremed Biodegrad 2: 104e. 2. AR, Lackman-Smith C (2009) Prevention of Human Immunodeficiency Virus Type 1 Transmission by Pharmaceuticals Targeted to Host Proteins Required for Virus Infection? Consideration of Farnesyl Thiosalicylic Acid, a Ras Inhibitor. J Antivir Antiretrovir 1: 72-75. 3. Moanna A, Skarbinski J, Kalokhe AS, Rimland D, Rouphael NG (2011) Primary Human Immunodeficiency Virus Infection and Rhabdomyolysis. J AIDS Clinic Res 2: 119. 4. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, et al. (2011) Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 365: 1492-501. 5. Guha P, Sardar P (2011) Prevalence of Paediatric HIV Infection in Eastern India-First report. J AIDS Clinic Res 2: 127. 6. Doukas N, Cullen J (2010) Recovered Addicts Working in the Addiction Field: How do Substance Abuse Treatment Agencies Work with Substance Abuse
Citation: Jeevani T (2011) Opportunistic Infections of Aids and Their Effects on Humans. J AIDS Clinic Res 2:132. doi:10.4172/2155-6113.1000132
Page 4 of 5
Relapse among Addiction Counsellors who are in Recovery? J Addict Res Ther 2: 106. 7. Lipshultz SE, Mas CM, Miller TL, Cordero C, Dauphin D, et al. (2011) The Effects of Fetal and Childhood Exposure to Antiretroviral Agents. J AIDS Clinic Res S2: 001. 8. Whitmore SK, Taylor AW, Espinoza L, Shouse RL, Lampe MA, et al. (2011) Correlates of Mother-to-Child Transmission of HIV in the United States and Puerto Rico. Pediatrics. 9. Talaber G, Perl A (2011) SLE: a Metabolic Disease of T Cells? Rheumatology 1: e103. 10. Tan DBA, Yong YK, Tan HY, French M, Kamarulzaman A, et al. (2010) Characteristics of Natural Killer Cells in Malaysian HIV Patients Presenting with Immune Restoration Disease After ART. J AIDS Clinic Res 1: 102. 11. Finlayson TJ, Le B, Smith A, Bowles K, Cribbin M, et al. (2011) HIV risk, prevention, and testing behaviors among men who have sex with men-National HIV Behavioral Surveillance System, 21 U.S. cities, United States, 2008. MMWR Surveill Summ 60: 1-34. 12. Vandevanter N, Duncan A, Raveis VH, Birnbaum J, Burrell-Piggott T, et al. (2011) Continued Sexual Risk Behaviour in African American and Latino Maleto-Female Transgender Adolescents Living with Hiv/Aids: A Case Study. J AIDS Clinic Res S1: 002. 13. Corra RB, Schmidt FR, Silva MLCF, Costa FHR, Rosso AL, et al. (2010) Holmes Tremor in an HIV Positive Patient Worsened by Immune Recovery Infl ammatory Syndrome (IRIS). J AIDS Clinic Res 1: 105. 14. Pineda JA, Alcam J, Blanco JR, Blanco J, Boix V, et al. (2011) Hot Immunological Topics in HIV Infection. J AIDS Clinic Res 2: 118. 15. Nogueira LM, Santos M, Ferreira LC, Talhari C, Rodrigues RR, et al. (2011) AIDS-associated paracoccidioidomycosis in a patient with a CD4+ T-cell count of 4 cells/mm. An Bras Dermatol 86: 129-132. 16. Achhra AC, Zhou J, Dabis F, Pujari S, Thiebaut R, et al. (2010) Difference in Absolute CD4+ Count According to CD4 Percentage between Asian and Caucasian HIV-Infected Patients. J AIDS Clinic Res 1: 101. 17. Jones N, Colver GB (2011) Skin Cancer Nurses - A Screening Role. J Clin Exp Dermatol Res 2: 130. 18. Mentzer A, Karalliedde J, Williams H, Guzder R, Ranja babu K (2010) Backache with Fever: A Unique Presentation of Advanced HIV Infection. J AIDS Clinic Res 1: 104. 19. Avila J (2011) A Possible Role for GSK3 in the Impaired Neurogenesis and Memory Loss Associated with Alzheimers Disease and Aging. J Alzheimers Dis 1: 102e. 20. Rady MY, Verheijde JL, Potts M (2011) Quality Palliative Care or Physicianassisted Death: A Comment on the French Perspective of End-of-life Care in Neurological Disorders. J Clinic Res Bioeth 2: 102e. 21. Yu L, Ma J, Ma R, Zhang Y, Zhang X, et al. (2011) Repair of Excitotoxic Neuronal Damage Mediated by Neural Stem Cell Lysates in Adult Mice. J Cell Sci Ther 2: 109. 22. Mungrue K, Roper LA, Chung T (2011) Assessment of Weight Loss in the Management of Patients with Type 2 Diabetes Mellitus in Primary Care in Trinidad. J Diabetes Metab 2: 120. 23. Verma D, Agarwal K, Wadhwa M, Shukla S, Prakash O (2011) T-Cell Lymphoblastic Lymphoma/Leukemia of Tenons Capsule of Eye: An Unusual Presentation. J Clinic Experiment Ophthalmol 2: 189. 24. Johnstone-Robertson SP, Hargrove J, Williams BG (2011) Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives? HIV AIDS (Auckl) 3: 9-17. 25. Thomas Kerr WS (2011) HIV Treatment as Prevention and the Role of Applied Social Science Research. J AIDS Clinic Res 2: 102e. 26. Seddon J, Bhagani S (2011) Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal. HIV AIDS (Auckl) 3: 19-33. 27. Tapia-Paniagua ST, Reyes-Becerril M, Ascencio-Valle F, Esteban M, Clavijo E, et al. (2011) Modulation of the Intestinal Microbiota and Immune System of Farmed Sparus aurata by the Administration of the Yeast Debaryomyces hansenii L2 in Conjunction with Inulin. J Aquac Res Development S1: 012. 28. Amare B, Tafess K, Ota F, Moges F, Moges B, et al. (2011) Serum Concentration of Selenium in Diarrheic Patients with and without HIV/AIDS in Gondar, Northwest Ethiopia. J AIDS Clinic Res 2: 128. 29. Bicanic T, Harrison TS (2005) Cryptococcal meningitis. Br Med Bull 72: 99-118. 30. Anekthananon T, Manosuthi W, Chetchotisakd P, Kiertiburanakul S, Supparatpinyo K, et al. (2011) Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients. Int J STD AIDS 22: 665-670. 31. Monpoux F, Pitelet G, Richelme C, Boutt P (2008) A case of acquired encephalopathy in a child. A cause that we thought had disappeared. Arch Pediatr 15: 1769-1771. 32. Christian E, Thorsten R HIV-1 associated Encephalopathy and Myelopathy. HIV encephalopathy 647-654. 33. Marzi A, Feldmann H, Geisbert TW, Falzarano D (2011) Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus Infections. J Bioterr Biodef S1: 004. 34. Tavazzi E, Ferrante P, Khalili K (2011) Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies. Clin Microbiol Infect 12: 1776-1780. 35. Osunkalu VO, Akanmu SA, Ofomah NJ, Onyiaorah IV, Adediran AA, et al. (2011) Seroprevalence of Toxoplasma gondii IgG antibody in HIV-infected patients at the Lagos University Teaching Hospital. HIV AIDS (Auckl) 3: 101-105. 36. Ebert EC (2011) Gastrointestinal Manifestations of Churg-Strauss Syndrome. J Gastrointest Digest Sys 1: 101. 37. Mehrkhani F, Jam S, Sabzvari D, Fattahi F, Kourorian Z, et al. (2011) Cytomegalovirus co-infection in patients with human immunodeficiency virus in Iran. Acta Med Iran 49: 551-555. 38. El-Tawil AM (2011) Gender and the Pathogenesis of Gastrointestinal Diseases: The Role of Steroid Sex Hormones in the Development. J Steroids Hormon Sci 2: 0e2. 39. Erhabor O, Obunge O, Awah I (2011) Cryptosporidiosis among HIV-infected persons in the Niger Delta of Nigeria. Niger J Med 20: 372-375. 40. Faye B, Tine RC, Ndiaye JL, Kintega C, Manga NM, et al. (2010) Impact of Intestinal Parasites on Intensity of HIV Infection in Senegal. J Antivir Antiretrovir 1: 11-12. 41. Hawkins CC, Gold JW, Whimbey E, Kiehn TE, Brannon P, et al. (1986) Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 105: 184-188. 42. El-Khatib Z, DeLong AK, Katzenstein D, Ekstrom AM, Ledwaba J, et al. (2011) Drug Resistance Patterns and Virus Re-Suppression among HIV-1 Subtype C Infected Patients Receiving Non-Nucleoside Reverse Transcriptase Inhibitors in South Africa. J AIDS Clinic Res 2: 117. 43. Ray A, Ray S, George AT, Swaminathan N (2011) Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection. Cochrane Database Syst Rev 8: CD008739. 44. Graver MA, Wade JJ (2010) Growth and Acidification by Vaginal Lactobacilli in Anaerobic Liquid Medium Over the pH Range 5.5 - 8.0. J Bacteriol Parasitol 1: 102. 45. Lee AJ, Ashkar AA (2011) Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development. Curr Opin Infect Dis. 46. Svensson A, Almqvist N, Chandy AG, Nordstrm I, Eriksson K (2010) Exposure to Human Herpes Virus Type 6 Protects Against Allergic Asthma in Mice. J Aller Ther 1: 101. 47. Blyta Y, Kocinaj A, Ferizi M, Gerqari A, Ahmeti N (2011) Multiforme Erythema, In Child, After Repeated Herpes Simplex Infections Case Presentation. J Clin Exp Dermatol Res 2: 127. 48. Carter MW, Kraft JM, Hatfield-Timajchy K, Hock-Long L, Hogben M (2011) STD and HIV Testing Behaviors Among Black And Puerto Rican Young Adults. Perspect Sex Reprod Health 43: 238-246. 49. Hu Y, Liang S, Zhu J, Qin G, Liu Q, et al. (2011) Factors Associated with Recent Risky Drug Use and Sexual Behaviors among Drug Users in Southwestern China. J AIDS Clinic Res 2: 120. 50. McBee WC Jr, Gardiner AS, Edwards RP, Lesnock JL, Bhargava R, et al. (2011)
Citation: Jeevani T (2011) Opportunistic Infections of Aids and Their Effects on Humans. J AIDS Clinic Res 2:132. doi:10.4172/2155-6113.1000132
Page 5 of 5
MicroRNA Analysis in Human Papillomavirus (HPV)- Associated Cervical Neoplasia and Cancer. J Carcinogene Mutagene 1: 114. 51. Lins Kusterer LEF (2011) Oral Diseases and Liver Pre and Post-Transplantation Disorders. J Transplant Technol Res S1: 001. 52. Mata RC, Mira JA, Rivero A, Lpez-Corts LF, Torres-Tortosa M, et al. (2010) Nevirapine-based Antiretroviral Therapy is Associated with Lower Plasma Hepatitis C Virus Viral Load among HIV/Hepatitis C Virus-Coinfected Patients. J AIDS Clinic Res 1: 110. 53. Mukherjee S (2009) Antiviral Therapy for Hepatitis B in Preand Post-liver Transplant Patients. J Antivir Antiretrovir 1: 17-27. 54. Sidiq H, Ankoma-Sey V (2006) HIV-related liver disease: infections versus drugs. Gastroenterol Clin North Am 35: 487-505. 55. Nellithady GS, Anila K, Kumar KK, Kaveri H (2010) Lack of Association of Chronic Liver Disease in Patients with Oral Lichen Lanus. J Carcinogene Mutagene 1: 113. 56. Furrer H, Chan P, Weber R, Egger M (2001) Increased risk of wasting syndrome in HIV-infected travellers: prospective multicentre study. Trans R Soc Trop Med Hyg 95: 484-486. 57. Kumar GSS, Venugopal AK, Selvan LDN, MarimuthuA, Keerthikumar S, et al. (2011) Gene Expression Profiling of Tuberculous Meningitis. J Proteomics Bioinform 4: 98-105. 58. Roy D, Guha P, Bandyopadhyay D, Sardar P, Chatterjee SK (2011) Pancytopenia with Hemophagocytic Syndrome Associated with Histoplasmosis in Acquired Immunodeficiency Syndrome: Description of 2 Case Studies and Literature Review. J AIDS Clinic Res 2: 115. 59. Ehui E, Doukour B, Kolia-Diafouka P, Aoussi E, Koffi E, et al. (2011) Intestinal Histoplasmosis with Histoplasma duboisii in a Patient Infected by HIV-1 in Abidjan (Ivory Coast). J AIDS Clinic Res 2: 125. 60. Gentile P, Scioli MG, Orlandi A, Cervelli V (2011) Review: Application of PlateletRich Plasma in Hard Tissue Defects. J Tissue Sci Eng S2: 001. 61. Orsi AT, Nogueira L, Chrusciak-Talhari A, Santos M, Ferreira LC, et al. (2011) Histoplasmosis and AIDS co-infection. An Bras Dermatol 86: 1025-1026. 62. Javed F W, Naseem A Ansari (2004) Pneumocystis carinii Infection. Arch Pathol Lab Med 128: 1023-1027. 63. Norcross EW, Sanders ME, Moore QC 3rd, Marquart ME (2011) Pathogenesis of A Clinical Ocular Strain of Streptococcus pneumoniae and the Interaction of Pneumolysin with Corneal Cells. J Bacteriol Parasitol 2: 108. 64. Saran R, Das G (2011) Tuberculosis the Ancient Disease Needs Intervention of Modern Tools. Mycobact Diseases 1: e103. 65. Nigam A, Singh AK, Singh SK, Singh N, Singh N, et al. (2011) Primary Mammary (Non-Hodgkin) Lymphoma of Breast: A Case Report. J Cancer Sci Ther 3: 173-175. 66. Gayed IW, Wahba H, Wan D, Joseph U, Murthy R (2010) Effect of Y-90 SIRSpheres Therapy for Multiple Liver Metastases in a Variety of Tumors. J Cancer Sci Ther 2: 43-46. 67. Powles T, Matthews G, Bower M (2000) AIDS related systemic non-Hodgkins lymphoma. Sex Transm Infect 76: 335-341. 68. Riley JM, Jenrette JM, Gordon L, Milligan L, Zauls AJ, et al. (2011) Progression of Nodular Lymphocyte-Predominant Hodgkins Lymphoma to a High-Grade Lymphoma. J Cell Sci Ther S2: 001. 69. Asiimwe F, Moore D, Were W, Nakityo R, Campbell, et al. (2011) Clinical outcomes of HIV-infected patients with Kaposis sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda. HIV Med. 70. Essadi I, Sbitti Y, Ichou M, Errihani H (2011) The Role of Chemotherapy in the Treatment of Kaposis Sarcoma. J Cancer Sci Ther 3: 145-148. 71. Tsipursky MS, Churgin DS, Conway MD, Peyman GA (2011) A Review of Photodynamic Therapy for Intraocular Tumors. J Anal Bioanal Techniques S1: 001. 72. http://www.nfid.org/pdf/factsheets/varicellaadult.pdf 73. Sprenger De Rover WB, Alazzawi S, Hallam PJ, Hutchinson R, Di Mascio L (2011) Herpes zoster virus: an unusual but potentially treatable cause of sciatica and foot drop. Orthopedics 34: 965-968.
Submit your next manuscript and get advantages of OMICS Group submissions
Unique features: User friendly/feasible website-translation of your paper to 50 worlds leading languages Audio Version of published paper Digital articles to share and explore
Special features: 200 Open Access Journals 15,000 editorial team 21 days rapid review process Quality and quick editorial, review and publication processing Indexing at PubMed (partial), Scopus, DOAJ, EBSCO, Index Copernicus and Google Scholar etc Sharing Option: Social Networking Enabled Authors, Reviewers and Editors rewarded with online Scientific Credits Better discount for your subsequent articles